Systematic Review with Meta-analysis: Association of Helicobacter pylori Infection with Esophageal Cancer
Open Access
- 1 December 2019
- journal article
- review article
- Published by Wiley in Gastroenterology Research and Practice
- Vol. 2019, 1-17
Abstract
Background. Helicobacter pylori is an important carcinogenic factor in gastric cancer. Studies have shown that Helicobacter pylori infection is inversely associated with certain diseases such as esophageal cancer and whose infection appears to have a “protective effect.” At present, the relationship between Helicobacter pylori infection and esophageal cancer remains controversial. This study was designed to investigate the relationship between Helicobacter pylori infection and the risk of esophageal cancer in different regions and ethnicities. Methods. Systematic search of the articles on the relationship between Helicobacter pylori infection and esophageal cancer from the database with the duration time up to December 2018. This systematic review was performed under the MOOSE guidelines. Results. This meta-analysis included 35 studies with 345,886 patients enrolled. There was no significant correlation between Helicobacter pylori infection and esophageal squamous cell carcinoma in the general population (OR: 0.84; 95% CI: 0.64-1.09/OR: 0.74; 95% CI: 0.54-0.97). However, a significant correlation was found in the Middle East (OR: 0.34; 95% CI: 0.22-0.52/95% CI: 0.26-0.44). There was no significant difference in the prevalence of Helicobacter pylori between the case group and the control group in esophageal adenocarcinoma (8.87% vs. 9.67%). The pooled OR was 0.55 (95% CI: 0.43-0.70) or 0.23 (95% CI: 0.15-0.36). When grouped by match or not, the pooled OR of the nonmatching group and the matching group was 0.48/0.21 (95% CI: 0.36-0.65/95% CI: 0.13-0.36) and 0.73/0.71 (95% CI: 0.57-0.92/95% CI: 0.60-0.84), respectively. Conclusion. In the general populations, no significant association was found between Helicobacter pylori infection and the risk of esophageal squamous cell carcinoma. However, lower risk was found in the Middle East. Helicobacter pylori infection may reduce the risk of esophageal adenocarcinoma, but such “protection effect” may be overestimated.Keywords
Funding Information
- Zhejiang Medicine Scientific and Technology Project (2019RC094, 2018258924)
- Zhejiang medicine key scientific and technology project (2019RC094, 2018258924)
This publication has 71 references indexed in Scilit:
- Serum ghrelin is inversely associated with risk of subsequent oesophageal squamous cell carcinomaGut, 2011
- Tobacco Smoking and Esophageal and Gastric Cardia AdenocarcinomaEpidemiology, 2011
- Meta‐analysis: the association of oesophageal adenocarcinoma with symptoms of gastro‐oesophageal refluxAlimentary Pharmacology & Therapeutics, 2010
- Serum Pepsinogens and Helicobacter pylori in Relation to the Risk of Esophageal Squamous Cell Carcinoma in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention StudyCancer Epidemiology, Biomarkers & Prevention, 2010
- Polymorphism in COX-2 modifies the inverse association between Helicobacter pyloriseropositivity and esophageal squamous cell carcinoma risk in Taiwan: a case control studyBMC Gastroenterology, 2009
- Sex-specific risk factor profile in oesophageal adenocarcinomaBritish Journal of Cancer, 2008
- Helicobacter pylori and Esophageal Cancer Risk: A Meta-analysisCancer Prevention Research, 2008
- Polymorphisms of inflammatory and metalloproteinase genes, Helicobacter pylori infection and the risk of oesophageal adenocarcinomaBritish Journal of Cancer, 2008
- Helicobacter pylori and oesophageal and gastric cancers in a prospective study in ChinaBritish Journal of Cancer, 2006
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986